You are here

Responses

Article menu

Download PDFPDF

Commentary
Children and adolescents in African countries should also be vaccinated for COVID-19
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 4 March 2022
    Covid-19 vaccination in Africa: a call for equity (and not equality)
    • David Bell, MBBS, PhD, FRCP(UK). FAFPHM. Public health expert Independent consultant
    • Other Contributors:
      • Elisabeth Paul, Associate Professor

    Dear Editor,

    We agree with Sam-Agudu et al. on the importance of equity in public health (1), and for these reasons raise major concerns regarding the remainder of the Commentary’s focus, and similar view prevalent in this Journal (2) and the wider global health community. We respectfully outline these here, as they affect the current health focus being applied to over a billion people in sub-Saharan countries.

    Sam-Agudu and co-authors state that ‘Global, equitable access to safe and effective vaccines for all age groups is critical to ending the COVID-19 pandemic’. This statement, reflecting those of the COVAX programme of the World Health Organization (WHO) and other agencies, is flawed. Equity in health means opportunity for good health, based on individual need, not measured by access to a particular pharmaceutical. A vaccine that does not significantly reduce transmission (3,4) will not end a pandemic, and where risk of severity is low from intrinsic or acquired immune status, will not significantly change outcomes. This flawed assertion also ignores costs of vaccination, both in potential adverse effects, and in resource diversion from other health programmes (public health programmes do not operate in isolation).
    Regarding the evidence base used to support their argumentation, and related expected benefits of vaccination, much of Sam-Agudu et al.’s arguments are based on the African Forum for Research and Education in Health (AFREhealth) study r...

    Show More
    Conflict of Interest:
    None declared.